Lymphoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been newly diagnosed with a type of blood cancer called ALL (acute lymphoblastic leukemia) that tests negative for a specific genetic marker called the Philadelphia chromosome, and who have not yet received treatment (apart from short-term use of prednisone or hydroxyurea)
- People aged 14 to 60 years old
- People whose general health and ability to carry out daily activities meets a certain minimum level, as assessed by their doctor using a standard scale (confirm with trial site)
- People whose liver, kidneys, and heart are functioning well enough to meet the trial's requirements (confirm with trial site)
- People who are capable of becoming pregnant and are willing to use effective contraception throughout the trial
- People who are willing and able to give their informed consent to participate
Who may not be able to join:
- People whose leukemia is specifically classified as Burkitt leukemia or Burkitt lymphoma
- People whose leukemia cannot be clearly identified as one specific type (sometimes called "ambiguous lineage")
- People who are currently pregnant or breastfeeding
- People who have a serious active infection that is not under control
- People who have a history of pancreatitis (inflammation of the pancreas)
- People with diabetes that is not well controlled, based on a specific blood test result (HbA1c above 7.5%)
- People who have experienced active bleeding in the stomach or intestines within the past 6 months
- People who have had a blood clot in an artery or vein within the past 6 months
- People who are known to be HIV positive
- People with a severe psychiatric or mental health condition that may make it difficult to follow the trial requirements
- People whom the trial investigators consider unsuitable for any other medical reason
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 13132507161
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Event-Free Survival; MRD-negative CR rate by flow cytometry after induction regimen
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.